U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07151924) titled 'Eating Disturbances in Patients With Type 1 Diabetes Initiating Insulin Therapy' on July 18.
Brief Summary: The prevalence of eating disorders is particularly high among people with type 1 diabetes (T1D). These abnormalities, such as "diabulimia," are frequently responsible for poor insulin therapy management and, consequently, chronic glycemic imbalance, exposing them to an increased risk of complications. Their detection and management unfortunately remain insufficient in current practice.
However, to date, no study has addressed the question of the prevalence and impact of eating disorders in this context. Our research hypothese...